Loading fund…
Loading fund…
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | ▲ +0.7% | ▲ +3.5% | ▲ +16.9% | ▲ +29.2% | ▲ +38.5% | ▲ +87.0% | ▲ +38.8% | ▲ +737.9% |
| Peer average | ▼ −1.0% | ▼ −4.0% | ▲ +1.7% | ▲ +13.4% | ▲ +9.3% | ▲ +90.3% | ▲ +37.9% | — |
| S&P 500 · VOO | ▼ −0.4% | ▲ +0.9% | ▲ +3.3% | ▲ +13.8% | ▲ +13.3% | ▲ +88.8% | ▲ +81.9% | — |
The iShares Biotechnology ETF (IBB) is designed to mirror the investment performance of a specific market index. This index comprises publicly traded stocks from companies operating within the U.S. biotechnology sector.
Distribution yield and SEC yield use different methodologies. Payouts may include income, capital gains, or return of capital.
| Ex-date | Pay date | Per share |
|---|---|---|
| 2026-09-15 | 2026-09-18 | $0.01 |
| 2026-06-15 | 2026-06-18 | $0.02 |
| 2026-03-17 | 2026-03-20 | $0.12 |
| 2025-12-16 | 2025-12-19 | $0.18 |
| 2025-09-16 | 2025-09-19 | $0.08 |
| 2025-03-18 | 2025-03-21 | $0.12 |
| 2024-12-17 | 2024-12-20 | $0.06 |
| 2024-09-25 | 2024-09-30 | $0.20 |
| 2024-03-21 | 2024-03-27 | $0.13 |
| 2023-12-20 | 2023-12-27 | $0.12 |
| 2023-09-26 | 2023-10-02 | $0.15 |
| 2023-06-07 | 2023-06-13 | $0.01 |
Estimated annual expense excludes trading costs and assumes constant assets. Fee waivers and fund costs can change.
Historical risk measures describe past behavior and do not predict future returns.
Hear the strategy from the people behind IBB.